Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
IDEAYA Biosciences, Inc. (IDYA) had Normalized Income after Taxes of $-83.27M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$10.88M |
|
$-83.27M |
|
-- |
|
$10.88M |
|
$105.45M |
|
$-94.57M |
|
$11.30M |
|
$-83.27M |
|
$-83.27M |
|
$-83.27M |
|
$-83.27M |
|
$-83.27M |
|
|
Normalized Income after Taxes |
$-83.27M |
$-94.57M |
|
$-94.90M |
|
88.48M |
|
88.48M |
|
$-0.93 |
|
$-0.91 |
|
| Balance Sheet Financials | |
$666.73M |
|
$8.22M |
|
$442.60M |
|
$1.11B |
|
$58.81M |
|
-- |
|
$27.57M |
|
$86.39M |
|
$1.02B |
|
$1.02B |
|
$1.02B |
|
87.80M |
|
| Cash Flow Statement Financials | |
$-71.10M |
|
$69.98M |
|
$29.78M |
|
$85.18M |
|
$113.84M |
|
$28.66M |
|
$46.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
11.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-869.53% |
|
-869.53% |
|
-- |
|
-765.66% |
|
-765.66% |
|
$-73.47M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-8.14% |
|
-8.14% |
|
-7.51% |
|
-8.14% |
|
$11.65 |
|
$-0.83 |
|
$-0.80 |
|